"10.1371_journal.pone.0021065","plos one","2011-06-22T00:00:00Z","Subhash Thalappilly; Xiaolan Feng; Svitlana Pastyryeva; Keiko Suzuki; Daniel Muruve; Daniel Larocque; Stephane Richard; Matthias Truss; Andreas von Deimling; Karl Riabowol; Gesche Tallen","Departments of Biochemistry and Molecular Biology and Oncology, University of Calgary, Calgary, Alberta, Canada; Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Preclinical Research Team on Neurodegenerative Diseases, Chronic Disorders DAP, GlaxoSmithKline Biologicals North America, Laval, Quebec, Canada; Department of Medicine and Oncology, Lady Davis Institute, McGill University, Montreal, Quebec, Canada; Laboratory for Molecular Biology, Department of Pediatrics, Charité - Universitätsmedizin Berlin, Berlin, Germany; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls University Heidelberg and Clinical Cooperation Unit Neuropathology, Heidelberg, Germany; Department of Pediatric Oncology/Haematology, Charité - Universitätsmedizin Berlin, Berlin, Germany","Conceived and designed the experiments: ST XF KR. Performed the experiments: ST XF SP KS. Analyzed the data: ST XF KR GT. Contributed reagents/materials/analysis tools: DM DL SR MT AvD. Wrote the paper: ST KR GT.","The authors have declared that no competing interests exist. D.L. is currently an employee of GlaxoSmithKline but GSK provided no support for this study and this affiliation presents no changes for adherence to all PLoS ONE policies on sharing data and materials.","2011","06","Subhash Thalappilly","ST",11,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
